Discovery of the 1,7-diazacarbazole class of inhibitors of checkpoint kinase 1.
Gazzard, L., Appleton, B., Chapman, K., Chen, H., Clark, K., Drobnick, J., Goodacre, S., Halladay, J., Lyssikatos, J., Schmidt, S., Sideris, S., Wiesmann, C., Williams, K., Wu, P., Yen, I., Malek, S.(2014) Bioorg Med Chem Lett 24: 5704-5709
- PubMed: 25453805 
- DOI: 10.1016/j.bmcl.2014.10.063
- Primary Citation of Related Structures:  
4QYE, 4QYF, 4QYG, 4QYH - PubMed Abstract: 
Checkpoint kinase 1 (ChK1) is activated in response to DNA damage, acting to temporarily block cell cycle progression and allow for DNA repair. It is envisaged that inhibition of ChK1 will sensitize tumor cells to treatment with DNA-damaging therapies, and may enhance the therapeutic window ...